Study of patient engagement in untreated tardive dyskinesia
Part of Brain & nervous system clinical trials.
This study looks at how people with tardive dyskinesia (a movement disorder) who have never been treated engage with their care. It aims to understand their patterns and experiences, which may help improve future treatment approaches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with tardive dyskinesia.
- You need to be at least 18 years old.
- You cannot have taken any treatment for tardive dyskinesia before.
- You cannot be part of another research study right now.
- You must be able to give written permission (informed consent) to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an oral medication, NBI-1065890, can reduce the involuntary muscle movements caused by long-term use of antipsychotic drugs. It is for adults with moderate to severe tardive dyskinesia who also have a stable mental health condition like schizophrenia or bipolar disorder.
This trial tests whether deutetrabenazine, a medication already used for tardive dyskinesia, can help people who also have intellectual or developmental disabilities. It aims to see if the drug reduces uncontrolled movements safely over 24 weeks.
This study tests whether a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS), targeted precisely using brain imaging, can safely reduce the involuntary movements caused by some psychiatric medications. If you have tardive dyskinesia, this treatment might help improve your motor symptoms.
This study tests if valbenazine helps adults with tardive dyskinesia whose symptoms continue even after taking or stopping another similar medication. Tardive dyskinesia involves uncontrollable movements from long-term use of certain mental health drugs.
This study looks at how people with depression that hasn't improved with standard treatments engage with their care. It aims to learn more about patterns that could help improve future treatment options.
This trial is looking at what it's like for people with keratoconus who have not yet had any treatment. It helps researchers understand how to better include patients in future studies.
Hear when a new Tardive Dyskinesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.